Publicaciones en colaboración con investigadores/as de Centre Hospitalier Universitaire de Liège (9)

2022

  1. Erratum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study (Oncotarget (2020) 11 (2172-2181) DOI: 10.18632/oncotarget.27612)

    Oncotarget

2021

  1. Expected medium- And long-term impact of the COVID-19 outbreak in oncology

    JCO Global Oncology, Vol. 7, pp. 162-172

2020

  1. Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

    Clinical and Translational Oncology, Vol. 22, Núm. 10, pp. 1857-1866

  2. Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

    Breast Cancer Research and Treatment, Vol. 184, Núm. 2, pp. 421-431

  3. Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: A retrospective exploratory analysis of the BALLET study

    European Journal of Cancer, Vol. 138, pp. S67

  4. Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study

    Oncotarget, Vol. 11, Núm. 23, pp. 2172-2181

2018

  1. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 1, pp. 127-138

2016

  1. Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

    Annals of Oncology, Vol. 27, Núm. 9, pp. 1719-1725

2014

  1. European inter-institutional impact study of MammaPrint

    Breast, Vol. 23, Núm. 4, pp. 423-428